Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith T Zemanick

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Pediatrics|March 25, 2016
Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic FibrosisThomas Lahiri, Sarah E Hempstead, Cynthia Brady, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 4, 2025
Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatmentEdith T Zemanick, Bonnie Ramsey, Dorota Sands, et al.
Chest|April 5, 2023
Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally Inserted Venous Catheters in People With Cystic Fibrosis StudyAlex H Gifford, Alexandra C Hinton, Shijing Jia, et al.
The European Respiratory Journal|November 18, 2017
Airway microbiota across age and disease spectrum in cystic fibrosisEdith T Zemanick, Brandie D Wagner, Charles E Robertson, et al.
ATS Scholar|April 19, 2021
Development of a National Academic Boot Camp to Improve Fellowship ReadinessMatthew G Drake, Nirav G Shah, May Lee, et al.
American Journal of Respiratory and Critical Care Medicine|March 18, 2021
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One <i>F508del</i> AlleleEdith T Zemanick, Jennifer L Taylor-Cousar, Jane Davies, et al.
ERJ Open Research|January 15, 2025
The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocolChristine M Liu, Jakob L Fischer, Edith T Zemanick, et al.
The Lancet. Respiratory Medicine|September 12, 2023
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveNicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, et al.
Frontiers in Microbiology|January 10, 2022
Bacterial Signatures of Paediatric Respiratory Disease: An Individual Participant Data Meta-AnalysisDavid T J Broderick, David W Waite, Robyn L Marsh, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Pediatrics|March 25, 2016
Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic FibrosisThomas Lahiri, Sarah E Hempstead, Cynthia Brady, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 4, 2025
Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatmentEdith T Zemanick, Bonnie Ramsey, Dorota Sands, et al.
Chest|April 5, 2023
Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally Inserted Venous Catheters in People With Cystic Fibrosis StudyAlex H Gifford, Alexandra C Hinton, Shijing Jia, et al.
The European Respiratory Journal|November 18, 2017
Airway microbiota across age and disease spectrum in cystic fibrosisEdith T Zemanick, Brandie D Wagner, Charles E Robertson, et al.
ATS Scholar|April 19, 2021
Development of a National Academic Boot Camp to Improve Fellowship ReadinessMatthew G Drake, Nirav G Shah, May Lee, et al.
American Journal of Respiratory and Critical Care Medicine|March 18, 2021
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One <i>F508del</i> AlleleEdith T Zemanick, Jennifer L Taylor-Cousar, Jane Davies, et al.
ERJ Open Research|January 15, 2025
The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocolChristine M Liu, Jakob L Fischer, Edith T Zemanick, et al.
The Lancet. Respiratory Medicine|September 12, 2023
Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspectiveNicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, et al.
Frontiers in Microbiology|January 10, 2022
Bacterial Signatures of Paediatric Respiratory Disease: An Individual Participant Data Meta-AnalysisDavid T J Broderick, David W Waite, Robyn L Marsh, et al.
Pageof 9